At Avidity, we are developing a new class of oligonucleotide-based therapies.
drug discovery and development β’ nucleic acids β’ RNA β’ rare disease
51 - 200
October 20
Lead medical affairs strategy for DMD at Avidity Biosciences.
πΊπΈ United States β Remote
π΅ $278.9k - $308.3k / year
β° Full Time
π Senior
π Director